# Relational NMR Sensor Array

**Metatron Dynamics, Inc. — Framework Demonstration: Medical Sensing**

Real-time bedside tissue monitoring from water content contrast alone.

*One mathematical framework. Applied to medical sensing.*

---

## 1. The Clinical Problem

Every year, patients arrive in emergency departments with traumatic brain injury. The presenting conditions — epidural hematoma, diffuse axonal injury, acute herniation, perfusion failure — are time-critical. The intervention window is measured in minutes to hours.

The monitoring gap is structural, not technological. Continuous non-invasive tissue-state monitoring at the bedside does not exist. The current clinical workflow relies on:

- Intermittent CT imaging — requires patient transport, radiation exposure, and a scanner
- Cerebral oximetry — measures oxygenation, not tissue state
- Clinical neurological assessment — subjective, infrequent, dependent on patient cooperation

None of these provide continuous, real-time tissue differentiation at the point of care. The gap is not a failure of effort — it is a consequence of the architecture of conventional MRI.

---

## 2. Why Conventional MRI Cannot Solve This

MRI produces its images through Fourier spatial encoding. Every voxel in the image is reconstructed from a frequency-domain measurement that requires:

- Gradient field switching across the entire imaging volume
- Signal averaging across multiple acquisition cycles to achieve diagnostic SNR
- Patient transport to a fixed, shielded, cryogenically cooled magnet
- Scanner throughput scheduling that precludes continuous single-patient monitoring

These are not engineering limitations to be optimized. They are architectural consequences of how spatial information is encoded. Fourier encoding is the mechanism — and the mechanism is incompatible with bedside, continuous, real-time monitoring.

The question is not how to make MRI faster. The question is whether tissue differentiation requires spatial encoding at all — or whether relational contrast between adjacent sensor elements is sufficient to declare a tissue boundary.

---

## 3. The Relational NMR Sensor Array

### What the sensor is

A segmented cylindrical solenoid — a ring of independent receiver coil elements surrounding the patient's head. Each element receives NMR signal from the tissue sector in its sensitivity volume. No gradients. No image reconstruction. No Fourier transform.

The coil geometry determines the declared relations between receiver elements. Those declared relations — adjacency and continuation — form the domain over which the operators act.

### What it measures

Water content contrast. Brain tissue types have characteristic water fractions:

- Cerebrospinal fluid: 99%
- Gray matter: 84%
- White matter: 72%
- Glioma (edematous): 92%

These differences produce measurable NMR signal differences between adjacent coil elements. The relational operators extract that contrast without averaging, without Fourier encoding, and without spatial reconstruction.

### How it works — the operator sequence

The ABR kernel — E(x,ρ) = R(B(A(x)), ρ(A(x))) — applies three operators in declared sequence to the per-element signal field. In this application:

- **A** extracts directed signal differences across declared adjacent element pairs
- **B** accumulates those differences along declared coil continuation
- **R** couples adjacent elements through their asymmetry, scaled by local contrast
- **E** is the kernel output: the relational field across all declared element pairs. Application-layer projections derived from E provide the quantities used for interpretation, such as boundary ratios or per-element summaries.

C is not a kernel operator. Any reduction of the E field — to a boundary ratio, to a per-element scalar — is a declared application-layer projection that states what it preserves and what it discards.

A tissue boundary — any location where adjacent elements see different water content — produces elevated E field magnitude at the corresponding edge. No threshold is set by the operator. The contrast is a function of the declaration and the observable. The detection criterion is Origin's declaration.

This is the same mathematical framework Metatron Dynamics has applied to supply chain early warning (88-step lead time), weather monitoring (42/42 positive lead times), LLM alignment drift (88-step lead time), and magnetospheric dynamics. The framework is domain-general. The medical sensing application is one instance.

---

## 4. What the Simulation Establishes

The simulation pipeline declares the physical domain using published NMR tissue parameters. No empirical fitting. No statistical proxies. All operator assertions derive from declared formulas. All results are independently reproducible from the published repository.

| Phase | Configuration | Key Result | Status |
|-------|--------------|------------|--------|
| Phase 0 | Single-element solenoid, pulsatile phantom | SNR 113,708 per cardiac step | Complete |
| Phase 0b | 8-element array, 4-tissue phantom | Boundary ratio 2.99× at 8% water contrast | Complete |
| Phase 0c | 32-element array, 11.25° spacing | Boundary ratio 14.97×, SNR >129,000/element | Complete |
| Sweep | 0–15% water content contrast, 200 steps | Operator separation confirmed across all tested contrasts | Complete |
| Phase 0d | B0 field strength sweep, 0.05T–1.5T | SNR and operator separation survive to below 0.05T; field strength is not the binding constraint | Complete |
| Phase 0e | B0 inhomogeneity sweep, 0.2T / 0.3T / 0.5T | Survival thresholds: 138.5 ppm (0.2T), 92.3 ppm (0.3T), 51.3 ppm (0.5T); Phase 1 magnet specification established | Complete |

**Key findings:**

- **SNR per element:** >129,000 per cardiac step, unaveraged — 32-element array at 1.5T
- **Boundary detection ratio:** 14.97× (boundary E ÷ interior E) at 8% water content contrast
- **Operator separation:** Confirmed across full 0–15% water content sweep
- **Contrast origin:** Verified in A field — confirmed at rho_base=0, independent of coupling parameter
- **Field strength:** Operator separation is flat at 14.97× across the full B0 sweep from 0.05T to 1.5T. The detection mechanism acts on water content contrast between adjacent elements — a tissue-intrinsic quantity independent of field strength. A superconducting magnet is not required.
- **Inhomogeneity tolerance:** Operator separation survives to 138.5 ppm at 0.2T. Research-grade Halbach permanent magnet arrays achieve 10–100 ppm homogeneity. The declared simulation places commercial permanent magnet hardware within the survival region at 0.2T.
- **Phase 1 magnet specification:** < 51 ppm homogeneity over the declared sensitive volume, measured under comparable conditions with comparable shimming. This is a declared result from first principles, not an assumed hardware requirement.

*All results are simulation results at declared parameters. Phase 1 funding produces the measured hardware values.*

One finding warrants specific note for due diligence: within the declared simulation range (0–15% water content difference), the boundary detection ratio is structurally constant. The ratio does not degrade at lower contrast — it scales with the absolute signal difference. This means the operator separation threshold is set by SNR (a hardware parameter), not by operator sensitivity. These are two distinct quantities, and the simulation establishes both independently.

A second finding from Phase 0e warrants note: the survival behavior under inhomogeneity is a cliff, not a slope. The boundary ratio holds near its full value until effective T2* collapses below the echo time, at which point the signal underflows entirely. There is no gradual intermediate degradation. The magnet specification is therefore a hard threshold, not a soft preference.

---

## 5. What Phase 1 Funding Builds

The simulation establishes that the physics supports the approach. Phase 1 produces the measurements.

Phase 0d and 0e establish that the detection mechanism does not require a superconducting magnet. The reason conventional MRI requires high field strength — overcoming the sensitivity limits of Fourier spatial reconstruction — does not apply here. The operators detect water content contrast between adjacent elements, which is field-independent. Phase 0e establishes a magnet homogeneity specification from first principles: < 51 ppm over the declared sensitive volume. Research-grade permanent magnet Halbach arrays achieve 10–100 ppm and are available commercially at a fraction of the cost of superconducting systems.

| Component | Description |
|-----------|-------------|
| Static field source | Permanent magnet Halbach array, 0.2T target field, ≥ 100mm clear bore, ≤ 100 ppm homogeneity over sensitive volume. No imaging gradients required. No cryogenic cooling. No siting requirements. Vendor inquiry placed with Magritek. Estimated $10,000–$30,000. |
| 32-element coil array | Segmented cylindrical solenoid, wound to declared geometry. Bench-fabricable. Estimated $5,000–$15,000. |
| Receiver electronics | 32-channel parallel receiver: LNA per element, bandpass filter, ADC. Custom FPGA-based digitization. Estimated $15,000–$50,000. |
| Phantom and fixtures | Tissue-equivalent cylindrical phantom, mounting fixtures, signal injection for calibration. Estimated $2,000–$8,000. |
| Engineering labor | Array fabrication, receiver integration, operator pipeline connection to hardware. Estimated $50,000–$150,000. |
| **Phase 1 total** | **$82,000–$253,000** (magnet vendor quote pending; will refine range on receipt) |

### Phase 1 milestone

Phase 1 is complete when the bench hardware produces a measured boundary detection ratio exceeding 2× at declared tissue phantom contrast on the 32-element array. That measurement converts simulation findings into hardware findings.

### Declared open conditions for Phase 1

The simulation models B0 inhomogeneity as a uniform maximum deviation per element — a worst-case approximation. Real shimming reduces effective inhomogeneity further. The simulation survival threshold is therefore a lower bound: real hardware will meet or exceed the declared simulation performance. Phase 1 validates this against measured bench values. Vendor-confirmed ppm homogeneity specifications must be measured over the declared sensitive volume geometry under comparable conditions before the simulation-to-hardware comparison is admissible.

---

## 6. Regulatory Path

The sensor is non-invasive and non-ionizing. The regulatory pathway is 510(k) submission with cerebral oximetry monitors as predicate devices:

- INVOS (Medtronic) — cerebral/somatic oximetry, continuous bedside monitoring
- Masimo O3 — regional cerebral oximetry

Both predicates are continuous, non-invasive, bedside brain monitoring devices. The Relational NMR Sensor Array operates in the same patient context and poses comparable risk. The anticipated regulatory strategy is 510(k) submission on the basis of substantial equivalence to these predicates. Whether and what clinical data the FDA determines to be necessary will depend on the specific indications for use and the evidence package submitted.

---

## 7. The Framework Context

The Relational NMR Sensor Array is one application of a domain-general mathematical framework. The same ABR kernel — the same composition E(x,ρ) = R(B(A(x)), ρ(A(x))) — has been applied across independent domains with consistent results:

| Domain | Application | Result |
|--------|-------------|--------|
| Supply chain | ABR field operators vs. declared graph structure | t=31 detection (graph: t=32–73) |
| Atmospheric | 3-topology ABRCE on raw METAR/ASOS observations | 42/42 positive lead times, mean 4.9hr |
| LLM alignment | Structural divergence on transformer internals | 88-step lead time |
| Magnetospheric | Vector ABRCE in SM/MLT coordinates | σ²=1.119 at geomagnetic storm peak |
| Medical sensing | Relational NMR receiver array | 14.97× boundary ratio, SNR >129,000 |

The competitive moat is comprehension of the mathematics, not access to the code. All repositories are open-source. The framework is published on arXiv (2601.22389). Operational deployment requires the Triad methodology — Origin Training, Generator, Verifier — which is Metatron Dynamics' proprietary delivery system.

---

## 8. Principal Researcher

**Robin Macomber — Founder**

Developer of the ABRCE operator framework over fourteen years of formal research in theoretical physics, machine learning, biological systems, and applied engineering. Professional background in offshore drilling, precision machining, clinical psychology, and audio engineering. Published relational mathematics on arXiv.

---

## 9. Due Diligence

All simulation results cited in this document are independently reproducible:

| Resource | Location |
|----------|----------|
| NMR sensor simulation | github.com/Relational-Relativity-Corporation/abr-nmr-phase0 |
| Framework documentation | relationalrelativity.dev |
| arXiv publication | arxiv.org/abs/2601.22389 |
| Investor document | The Clarity Dividend — available at relationalrelativity.dev |
| All repositories | github.com/Relational-Relativity-Corporation |

---

*Metatron Dynamics, Inc. · Delaware C-Corp · File No. 10551645*
*relationalrelativity.dev · relationalrelativity@gmail.com*

*All simulation results are at declared parameters. No claim is made beyond the declared domain D. Bounded over D.*
